These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders. Hall LD; Eminger LA; Hesterman KS; Heymann WR J Am Acad Dermatol; 2015 Jan; 72(1):1-19; quiz 19-20. PubMed ID: 25497917 [TBL] [Abstract][Full Text] [Related]
26. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma. Toksoy A; Strifler S; Benoit S; Grigoleit GU; Knop S; Mielke S; Buder-Bakhaya K; Roth S; Goebeler M; Rosenwald A; Geissinger E; Wobser M Acta Derm Venereol; 2017 Mar; 97(3):379-380. PubMed ID: 27826612 [No Abstract] [Full Text] [Related]
27. Hydroa Vacciniforme-Like T-Cell Lymphoma: A Further Brazilian Case. Miranda MFR; Santos JEBD; Müller SFR; Bittencourt MJS; Brito AC; Barros Junior JNDS; Xerfan EMS Am J Dermatopathol; 2018 Mar; 40(3):201-204. PubMed ID: 28248720 [TBL] [Abstract][Full Text] [Related]
28. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells. Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643 [TBL] [Abstract][Full Text] [Related]
29. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases. Liu Y; Ma C; Wang G; Wang L J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082 [TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544 [TBL] [Abstract][Full Text] [Related]
31. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells. Tanaka C; Hasegawa M; Fujimoto M; Iwatsuki K; Yamamoto T; Yamada K; Kawa K; Saikawa Y; Toga A; Mase S; Wada T; Takehara K; Yachie A Br J Dermatol; 2012 Jan; 166(1):216-8. PubMed ID: 21729029 [No Abstract] [Full Text] [Related]
32. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador. Montalvo N; Redrobán L Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846 [TBL] [Abstract][Full Text] [Related]
33. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder. Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959 [TBL] [Abstract][Full Text] [Related]
34. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review. Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199 [TBL] [Abstract][Full Text] [Related]
36. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases. Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837 [TBL] [Abstract][Full Text] [Related]
37. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. El-Mallawany NK; Geller L; Bollard CM; Wistinghausen B; Mussai F; Wayne AS; Alobeid B; Cairo MS Bone Marrow Transplant; 2011 May; 46(5):759-61. PubMed ID: 20661233 [No Abstract] [Full Text] [Related]
38. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites. Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668 [TBL] [Abstract][Full Text] [Related]
39. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411 [TBL] [Abstract][Full Text] [Related]
40. Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature. Wang M; Wang S; Yang QP; Liu YM; Gao LM; Sun H; Liu WP Diagn Pathol; 2013 May; 8():72. PubMed ID: 23635342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]